The definition of medical device under the FDA law and rules is quite broad. For makings of health care software, equipment and devices, it is not a trivial exercise to try to understand if you might be subject to FDA jurisdiction. As smart phone, tablet and other wireless device use has exploded, a large number of consumer and professional health care devices and applications have been created and marketed. The FDA recently issued a draft guidance designed to help vendors understand what they may need to do to comply with the medical device regulations. (Wellness Guidance) The first guidance is specifically directed at “wellness” devices and is a guidance for “low risk” ones. Using the usual FDA weasel words, it says that the FDA won’t examine “low risk general wellness products” to determine if they are devices as defined by the law. So how do you know if your product is a general wellness product? They have to be only for that use and they have to present a “very low risk” to users’ safety. According to the FDA, they could be exercise equipment, video games, audio recordings, software programs, usually available at retail outlets. So far, not much help. Here is a little more. A general wellness product is one that has “an intended use that relates to a maintaining or encouraging a general state of health or a healthy activity” or the associates the role of a healthy lifestyle with reducing the risk of chronic disease. It can’t make any claims in regard to specific diseases, but can refer to weight management, physical fitness, relaxation or stress management, self-esteem, sleep management or sexual function. Any claims that a product will help diagnose or treat a specific disease or condition makes it not a “general wellness product”. So you can’t say it will treat obesity or anxiety. It is okay, however, to claim your product has a use that will promote, track or encourage choices which may help reduce the risk of, or may help living well, with specific “chronic ” diseases. All clear now? And low risk means the product can’t be invasive, raise questions about biocompatibility, raise “novel questions about usability”, or involve an intervention or technology that may pose a risk to the user if controls aren’t applied. Clearer yet, eh! Anyhow, it is nice that they are trying.
FDA Guidances Affecting Wellness Devices and Apps
By Kevin RocheJanuary 29, 2015Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…
March 24, 2023
A Couple of Health Care Notes
A couple of pieces of health care research focus on high health care spending and…